RecruitingNot ApplicableNCT07222722

NIRS Monitoring in the NICU and AKI

Near Infrared Spectroscopy (NIRS) Monitoring as an Early Predictor of Acute Kidney Injury (AKI) in a Vulnerable Neonatal Intensive Care Unit (NICU) Population

Sponsor

NYU Langone Health

Enrollment

100 participants

Start Date

Nov 1, 2025

Study Type

INTERVENTIONAL

Conditions

Acute Kidney Injury (AKI)Postnatal AKI

Summary

The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.

Eligibility

Min Age: 24 WeeksMax Age: 30 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called NIRS Monitoring for people with acute kidney injury (aki) and postnatal aki. The study is currently recruiting participants at 1 location. People eligible for this study include aged 24 Weeks to 30 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENIRS Monitoring

The renal NIRS device is a non-invasive tool that uses near-infrared light to measure oxygen saturation various tissues. Renal NIRS sensors will be placed by 24 hours of the participants' admission.